Page 183 - IJB-9-2

International Journal of Bioprinting 3D Printing Multifunctional Orthopedic Biocoatings

Acta Biomaterialia. 2010;6(12):4457-4475. doi:10.1016/J. Staphylococcus aureus: Facts and assumptions. Lancet Infect
ACTBIO.2010.06.031 Dis, 9: 617–624.
71. Habibovic P, Barralet JE, 2011, Bioinorganics and https://doi.org/10.1016/S1473-3099(09)70200-2
biomaterials: Bone repair. Acta Biomater, 7: 3013–3026. 81. Peña J, Corrales T, Izquierdo-Barba I, et al., 2006, Long
https://doi.org/10.1016/J.ACTBIO.2011.03.027 term degradation of poly(ɛ-caprolactone) films in
biologically related fluids. Polym Degradation Stability,
72. Hoppe A, Güldal NS, Boccaccini AR, 2011, A review 91: 1424–1432.
of the biological response to ionic dissolution products
from bioactive glasses and glass-ceramics. Biomaterials, https://doi.org/10.1016/J.POLYMDEGRADSTAB.2005.10.016
32: 2757–2774. 82. Yeh ML, Chen KH, Chen HD, et al., 2013, Prolonged
https://doi.org/10.1016/J.BIOMATERIALS.2011.01.004 antibiotic release by PLGA encapsulation on titanium alloy.
J Med Biol Eng, 2013 33(1): p 5.
73. Lee SH, Lee JE, Baek WY, et al., 2004, Regional delivery
of vancomycin using pluronic F-127 to inhibit methicillin 83. Kim HW, Lee EJ, Jun IK, et al., 2005, Degradation and
resistant Staphylococcus aureus (MRSA) growth in chronic drug release of phosphate glass/polycaprolactone biological
otitis media in vitro and in vivo. J Controlled Release, 96: 1–7. composites for hard-tissue regeneration. J Biomed Mater Res
Part B Appl Biomater, 75B: 34–41.
https://doi.org/10.1016/J.JCONREL.2003.12.029
https://doi.org/10.1002/JBM.B.30223
74. Ginebra MP, Traykova T, Planell JA, 2006, Calcium
phosphate cements as bone drug delivery systems: A review. 84. Fang T, Wen J, Zhou J, et al., 2012, Poly (ε-caprolactone)
J Control Release, 113: 102–110. coating delays vancomycin delivery from porous chitosan/
β-tricalcium phosphate composites. J Biomed Mater Res
https://doi.org/10.1016/J.JCONREL.2006.04.007 Part B Appl Biomater, 100B: 1803–1811.
75. Edin ML, Miclau T, Lester GE, et al., 1996, Effect of cefazolin https://doi.org/10.1002/JBM.B.32747
and vancomycin on osteoblasts in vitro. Clin Orthop Relat
Res, 333: 245–251. 85. Uskokovic̈ V, Desai TA, 2013, Phase composition control of
calcium phosphate nanoparticles for tunable drug delivery
76. Antoci V Jr., Adams CS, Hickok NJ, et al., 2007, Antibiotics kinetics and treatment of osteomyelitis. II. Antibacterial and
for local delivery systems cause skeletal cell toxicity in vitro. osteoblastic response. J Biomed Mater Res A, 101: 1427–1436.
Clin Orthop Rel Res, 462: 200–206.
https://doi.org/10.1002/JBM.A.34437
https://doi.org/10.1097/BLO.0B013E31811FF866
86. Kirkham J, Brookes SJ, Shore RC, et al., 2002, Physico-
77. Haleem AA, Rouse MS, Lewallen DG, et al., 2004, chemical properties of crystal surfaces in matrix–mineral
Gentamicin and vancomycin do not impair experimental interactions during mammalian biomineralisation. Curr
fracture healing. Clin Orthop Rel Res,427: 22–24. Opin Colloid Interface Sci, 7: 124–132.
https://doi.org/10.1097/01.BLO.0000144477.43661.59 87. Dos Santos EA, Farina M, Soares GA, et al., 2008, Surface
78. McLaren JS, White LJ, Cox HC, et al., 2014, A biodegradable energy of hydroxyapatite and β-tricalcium phosphate
antibiotic-impregnated scaffold to prevent osteomyelitis in ceramics driving serum protein adsorption and osteoblast
a contaminated in vivo bone defect model. Eur Cells Mater, adhesion. J Mater Sci Mater Med, 19: 2307–2316.
27: 332–349. https://doi.org/10.1007/S10856-007-3347-4/FIGURES/7
https://doi.org/10.22203/ECM.V027A24 88. Mueller B, Zacharias M, Rezwan K, 2010, Bovine serum
79. Mason EO, Lamberth LB, Hammerman WA, et al., 2009, albumin and lysozyme adsorption on calcium phosphate
Vancomycin MICs for Staphylococcus aureus vary by particles. Adv Eng Mater, 12: B53–B61.
detection method and have subtly increased in a pediatric https://doi.org/10.1002/ADEM.200980024
population since 2005. J Clin Microbiol, 47: 1628–1630.
89. Combes C, Rey C, 2010, Amorphous calcium phosphates:
https://doi.org/10.1128/JCM.00407-09 Synthesis, properties and uses in biomaterials. Acta
Biomater, 6: 3362–3378.
80. Moise PA, North D, Steenbergen JN, et al., 2009, Susceptibility
relationship between vancomycin and daptomycin in https://doi.org/10.1016/J.ACTBIO.2010.02.017

Volume 9 Issue 2 (2023) 175 https://doi.org/10.18063/ijb.v9i2.661